Versant Capital Management’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$157K Sell
4,053
-1,304
-24% -$48.4K 0.01% 723
2026
Q1
$214K Sell
5,357
-4,502
-46% -$213K 0.02% 562
2025
Q4
$450K Buy
9,859
+1,490
+18% +$68.9K 0.06% 244
2025
Q3
$371K Buy
8,369
+470
+6% +$22.5K 0.05% 291
2025
Q2
$379K Buy
7,899
+2,587
+49% +$113K 0.06% 250
2025
Q1
$210K Buy
5,312
+4,577
+623% +$193K 0.04% 407
2024
Q4
$33.8K Buy
+735
New +$32.9K 0.01% 749
2023
Q3
Sell
-6
Closed -$270 2033
2023
Q2
$270 Buy
+6
New +$289 ﹤0.01% 1952

Other funds holding QGEN

Versant Capital Management's QGEN Position: Q2 2026 in Review

Versant Capital Management reduced its Qiagen (QGEN) stake by 24% in Q2 2026, selling an estimated $48.4K and leaving 4,053 shares worth $157K. The position accounts for 0.01% of the portfolio, ranked #723.

Versant Capital Management first reported a position in QGEN in Q2 2023 and has held it in 8 quarters since. The position peaked at $450K in Q4 2025. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Versant Capital Management held 4,053 shares of Qiagen worth $157K as of Q2 2026.
  • Versant Capital Management sold 1,304 Qiagen shares in Q2 2026, an estimated $48.4K.
  • Qiagen made up 0.01% of Versant Capital Management's portfolio in Q2 2026, its #723 holding.
  • Versant Capital Management first reported a position in Qiagen in Q2 2023 and has held it in 8 quarters since.
  • Versant Capital Management's Qiagen position peaked at $450K in Q4 2025.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.